within Pharmacolibrary.Drugs.B_BloodAndBloodFormingOrgans.B03X_OtherAntianemicPreparations.B03XA02_DarbepoetinAlfa;
model DarbepoetinAlfa 
   extends Pharmacolibrary.Drugs.ATC.B.B03XA02;

  annotation(Documentation(
    info ="<html><body><p>Darbepoetin alfa is a synthetic analog of erythropoietin used to stimulate erythropoiesis. It is approved for the treatment of anemia associated with chronic kidney disease (CKD) and chemotherapy-induced anemia in cancer patients. It is longer-acting than recombinant human erythropoietin due to additional sialic acid groups.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic parameters in adults with chronic kidney disease after intravenous and subcutaneous administration. Subjects included both male and female patients, 18 to 75 years old, with stable renal function.</p><h4>References</h4><ol><li><p>Ibbotson, T, &amp; Goa, KL (2001). Darbepoetin alfa. <i>Drugs</i> 61(14) 2097–2106. DOI:<a href=&quot;https://doi.org/10.2165/00003495-200161140-00007&quot;>10.2165/00003495-200161140-00007</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/11735636/&quot;>https://pubmed.ncbi.nlm.nih.gov/11735636</a></p></li><li><p>Heatherington, AC, et al., &amp; Schueller, J (2006). Pharmacokinetics of darbepoetin alfa after intravenous or subcutaneous administration in patients with non-myeloid malignancies undergoing chemotherapy. <i>Clinical pharmacokinetics</i> 45(2) 199–211. DOI:<a href=&quot;https://doi.org/10.2165/00003088-200645020-00005&quot;>10.2165/00003088-200645020-00005</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/16485917/&quot;>https://pubmed.ncbi.nlm.nih.gov/16485917</a></p></li><li><p>Roberts, JK, et al., &amp; Sherwin, CM (2015). Population Pharmacokinetics of Darbepoetin Alfa in Conjunction with Hypothermia for the Treatment of Neonatal Hypoxic-Ischemic Encephalopathy. <i>Clinical pharmacokinetics</i> 54(12) 1237–1244. DOI:<a href=&quot;https://doi.org/10.1007/s40262-015-0286-y&quot;>10.1007/s40262-015-0286-y</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/25989868/&quot;>https://pubmed.ncbi.nlm.nih.gov/25989868</a></p></li></ol></body></html>",
    revisions = "<html><body><ul><li>06/2025 model generated by LLM gpt-4.1, references by scholarly and scripts created by Tomas Kulhanek</li></ul></body></html>",
    experiment(StartTime = 0, StopTime = 86400, Tolerance = 1e-09, Interval = 1)
  ));  
end DarbepoetinAlfa;
